<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title>High Grade Sarcoma Clinical Trials Updates During the Last 45 Days</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/results/term=High+Grade+Sarcoma</link><description>Clinical trials database search returned 
 results for the query High Grade Sarcoma AND ( "12/31/2011" : MAX ) [LAST-RELEASE-DATE].</description><pubDate>Tue, 14 Feb 2012 10:27:45 GMT</pubDate><atom:link href="http://www.clinicaltrialsfeeds.org/clinical-trials/rss/term=High+Grade+Sarcoma" rel="self" type="application/rss+xml" /><item><title>Methionine PET/CT Studies In Patients With Cancer</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00840047</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00840047</guid><description>Status: Recruiting, 
Condition Summary: Brain Tumors and /or Solid Tumors Including:; Brain Stem Glioma; High Grade CNS Tumors; Ependymoma; Medulloblastoma; Craniopharyngioma; Low Grade CNS Tumors; Hodgkin Lymphoma; Non Hodgkin Lymphoma; Ewing Sarcoma; Osteosarcoma; Rhabdomyosarcoma; Neuroblastoma; Other</description><pubDate>Fri, 03 Feb 2012 05:00:00 GMT</pubDate></item><item><title>Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00346164</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00346164</guid><description>Status: Recruiting, 
Condition Summary: Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma</description><pubDate>Fri, 10 Feb 2012 05:00:00 GMT</pubDate></item><item><title>Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00004853</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00004853</guid><description>Status: Completed, 
Condition Summary: Ewing's Sarcoma; Rhabdomyosarcoma; Sarcoma; Synovial Sarcoma</description><pubDate>Fri, 06 Jan 2012 05:00:00 GMT</pubDate></item><item><title>HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00931931</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00931931</guid><description>Status: Recruiting, 
Condition Summary: Non-CNS Solid Tumors</description><pubDate>Thu, 09 Feb 2012 05:00:00 GMT</pubDate></item><item><title>Collecting and Storing Tissue From Young Patients With Cancer</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00898755</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00898755</guid><description>Status: Recruiting, 
Condition Summary: Cancer</description><pubDate>Thu, 09 Feb 2012 05:00:00 GMT</pubDate></item><item><title>Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00282087</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00282087</guid><description>Status: Completed, 
Condition Summary: Leiomyosarcoma; Uterine Neoplasm</description><pubDate>Thu, 26 Jan 2012 05:00:00 GMT</pubDate></item><item><title>Donor Atorvastatin Calcium in Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Blood Stem Cell Transplant</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01525407</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01525407</guid><description>Status: Not yet recruiting, 
Condition Summary: Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blastic Phase Chronic Myelogenous Leukemia; Burkitt Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Chronic Eosinophilic Leukemia; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; de Novo Myelodysplastic Syndromes; Disseminated Neuroblastoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; High Risk Metastatic Gestational Trophoblastic Tumor; Juvenile Myelomonocytic Leukemia; Low Risk Metastatic Gestational Trophoblastic Tumor; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Plasma Cell Neoplasm; Previously Treated Childhood Rhabdomyosarcoma; Previously Treated Myelodysplastic Syndromes; Primary Myelofibrosis; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Rhabdomyosarcoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Gestational Trophoblastic Tumor; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Malignant Testicular Germ Cell Tumor; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Neuroblastoma; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Small Lymphocytic Lymphoma; Recurrent Wilms Tumor and Other Childhood Kidney Tumors; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage II Ovarian Epithelial Cancer; Stage II Ovarian Germ Cell Tumor; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Malignant Testicular Germ Cell Tumor; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Ovarian Epithelial Cancer; Stage III Ovarian Germ Cell Tumor; Stage III Small Lymphocytic Lymphoma; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Breast Cancer; Stage IV Childhood Hodgkin Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor; Stage IV Small Lymphocytic Lymphoma</description><pubDate>Thu, 02 Feb 2012 05:00:00 GMT</pubDate></item><item><title>Treatment of Endometrial Cancer</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01512810</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01512810</guid><description>Status: Recruiting, 
Condition Summary: Endometrial Cancer</description><pubDate>Thu, 19 Jan 2012 05:00:00 GMT</pubDate></item><item><title>Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00686738</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00686738</guid><description>Status: Recruiting, 
Condition Summary: Osteosarcoma</description><pubDate>Mon, 23 Jan 2012 05:00:00 GMT</pubDate></item><item><title>Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00582816</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00582816</guid><description>Status: Recruiting, 
Condition Summary: Leukemia; Solid Tumors</description><pubDate>Thu, 19 Jan 2012 05:00:00 GMT</pubDate></item></channel></rss>

